Submitted abstracts will be evaluated by Scientific Advisory Board (SAB), and opportunity for oral presentation will be provided for abstracts that are evaluated as excellent.
For abstracts submitted from abroad, travel grants (not be more than six years post-doctoral) will be provided based on the evaluation.
European and American Countries:$1500 /Asian Countries:$500.
Submission Period
Updated Submission Deadline: December 24, 2019 17:00 (JST)
January 8, 2020 17:00 (JST)
Abstract Submission has been closed.
Thank you for your submission.
Note: Abstract submissions can only be made electronically through the congress website.
General Guidelines
- Abstracts may be posted in the venue. For those abstracts rated as “excellent” only a limited number of travel grants will be provided for oral presentations. Please note that your preferred presentation format may not necessarily be granted. The final decision rests with the Organizing Committee.
- The body of abstracts should contain a maximum of 400 words and must be in English.
- The abstracts should be constructed with clear paragraphs for objectives, methods, results, and conclusions.
- Abstracts must be submitted via the congress website.
- Notification of abstract acceptance will be sent to the presenter (first author) by the end of January 2020.
- The Organizing Committee reserves the right to reject any abstract that does not meet the congress’ criteria.
【Abstract Category】
- Disease Modifying Therapy
- Symptomatic Treatment
- Neurobiology and Neuropathology
- Biomarkers and Neuroimaging
- Diagnosis
- Natural History
- Genetics
ID and Password
- After registering your abstract, you will receive a confirmation e-mail with your login ID and password codes.
- During the submission period, you may edit your abstract with your ID and password. Please retain them securely for future reference.
- If you do not receive any confirmation by e-mail, please contact the Secretariat:
msac2020-abs@congre.co.jp
Speaker Disclosure of Potential Conflicts of Interest
The presenter (the first author) must disclose any conflicts of interests.